Advertisement
Screener

Citius Pharmaceuticals, Inc. (CTXR) Revenue, Remaining Performance Obligation, Percentage

1.7 / 5 stars · 18/54 Roast Me

Citius Pharmaceuticals, Inc. Revenue, Remaining Performance Obligation, Percentage

Citius Pharmaceuticals, Inc. (CTXR) had Revenue, Remaining Performance Obligation, Percentage of 2.00% as of 2025-07-15, per its 10-Q filed 2026-08-14.

Financial Statements › Notes

us-gaap:RevenueRemainingPerformanceObligationPercentage · last filed 2026-08-14

  • 2025-07-15: Revenue, Remaining Performance Obligation, Percentage 2.00%.
  • 2024-03-31: Revenue, Remaining Performance Obligation, Percentage 50.00%.
  • 2023-12-31: Revenue, Remaining Performance Obligation, Percentage 50.00%.
  • 2023-09-30: Revenue, Remaining Performance Obligation, Percentage 50.00%.
Period endRevenue, Remaining Performance Obligation, Percentage
2025-07-152.00%
10-Q · filed 2026-08-14
2024-03-3150.00%
10-Q · filed 2024-05-14
2023-12-3150.00%
10-Q · filed 2024-02-14
2023-09-3050.00%
10-K · filed 2023-12-29
2023-06-3050.00%
10-Q · filed 2023-08-14
2023-03-3150.00%
10-Q · filed 2023-05-12
2022-12-3150.00%
10-Q · filed 2023-02-10
2022-09-3050.00%
10-K · filed 2022-12-22
2022-06-3050.00%
10-Q · filed 2022-08-11
2022-03-3150.00%
10-Q · filed 2022-05-12
2021-12-3150.00%
10-Q · filed 2022-02-10
2021-09-3050.00%
10-K · filed 2021-12-15
2021-06-3050.00%
10-Q · filed 2021-08-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36